M&A Deal Summary |
|
|---|---|
| Date | 2025-07-31 |
| Target | Avanos Medical - Hyaluronic Acid Product Line |
| Sector | Medical Products |
| Buyer(s) | Channel-Markers Medical |
| Sellers(s) | Avanos |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Medical Products |
Channel-Markers Medical is a privately held medical device company specializing in the development and commercialization of joint health, regenerative therapies, and minimally invasive pain management solutions. Channel-Markers Medical is based in Raleigh, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Georgia M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 2014 |
| Sector | Medical Products |
| Employees | 2,227 |
| Revenue | 688M USD (2024) |
Avanos is a medical technology company that provides healthcare solutions focused on preventing infection, eliminating pain and speeding recovery. Avanos was founded in 2014 and is based in Alpharetta, Georgia.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Medical Products M&A | 2 of 3 |
| Type: Divestiture M&A Deals | 2 of 3 |
| State: Georgia M&A | 2 of 3 |
| Country: United States M&A | 2 of 3 |
| Year: 2025 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-19 |
Diros Technology
Toronto, Ontario, Canada Diros Technology is a manufacturer of innovative radiofrequency (RF) products used to treat chronic pain conditions. Diros develops and markets a portfolio of products including RF generators, cannulae and unique tined probe technology marketed under the Trident™ brand. Diros Technology is based in Toronto, Ontario. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-09-15 |
Nexus Medical
Lenexa, Kansas, United States Nexus Medical is a medical device company that invented the anti-reflux category in needleless connectors to solve the unintended consequences of blood reflux in IV catheters, including intraluminal thrombotic occlusions, catheter failure, and infections. Nexus Medical was formed in 2001 and is based in Lenexa, Kansas. |
Buy | - |
